COVID-19: Avigan Granted to 38 Countries: 25EU, 6Asia, 5MiddleEast
Japanese goverment:
The grant will be implemented under the framework of the government’s Emergency Grant Aid Cooperation, which will total 1 million dollars (about 110 million yen).
Transportation is handled by UN agencies.
Ship from Avegan sequentially from the countries where the procedures are completed.
The target country will be requested to provide data on the effects of administration, which will be used to enhance Japanese knowledge.
Foreign Minister Mogi:
Many cases have emerged that have therapeutic effects.
He said he would like to expand clinical research not only in Japan but also internationally.
Ministry of Health, Labor and Welfare:
The guideline for research participation was compiled and notified to medical institutions nationwide on the 27th for the approval of Abigan.
Accelerate analysis by collecting a lot of clinical data as soon as possible.
Already about 1100 medical institutions have participated in the study and have been administered to more than 2000 people.
Research Objective: Use of Avgigan
- Prior approval by medical institution / ethics review committee
- Patient consent
- Providing data to the Ministry of Health, Labor and Welfare research group
Yomiuri Shimbun Online
https://www.yomiuri.co.jp/politics/20200428-OYT1T50212/
Japan to offer anti-flu drug Avigan to 38 countries as early as this week
APR 29, 2020
Japan will begin providing the anti-flu drug Avigan for free to 38 countries
as early as this week for treating patients with the new coronavirus, according to Foreign Minister Toshimitsu Motegi.
At a news conference Tuesday, Motegi also
said over 70 countries,
including the 38, have made requests for Avigan to Japan, which has decided to offer a $1 million grant to the United Nations Office for Project Services to buy and distribute the drug, also known as favipiravir, to countries that want it.
“I’ve heard that (the U.N. agency) is arranging to start transporting the drug around the holidays after procedures have been completed,”
Motegi told the news conference, referring to the last five days of the Golden Week holidays from Saturday through next Wednesday.
Among the 38 nations are
- 25 European countries, mostly from Eastern Europe,
- six in Asia including the Philippines and Malaysia,
- five in the Middle East such as Kuwait and two from other regions,
Motegi said
Japan will be provided with data obtained from clinical tests on COVID-19 patients that will be conducted in the recipient countries using the drug, which was developed by a group firm of Fujifilm Holdings Corp.
The Japan Times
https://www.japantimes.co.jp/news/2020/04/29/national/japan-avigan-drug-38-countries/#.XqowR0FcWEd